Literature DB >> 24318879

Role of annexin A5 in cisplatin-induced toxicity in renal cells: molecular mechanism of apoptosis.

Jin-Joo Jeong1, Nahee Park, Yeo-Jung Kwon, Dong-Jin Ye, Aree Moon, Young-Jin Chun.   

Abstract

Annexin A5 belongs to a large family of calcium-binding and phospholipid-binding proteins and may act as an endogenous regulator of various pathophysiological processes. There is increasing evidence that annexin A5 is related to cytotoxicity, but the precise function of this protein has yet to be elucidated. In this study, we aimed to verify the function of annexin A5 in the apoptosis of renal epithelial cells. Real-time PCR and Western blot analysis, together with immunofluorescence analysis, showed that the expression of annexin A5 significantly increased in the presence of cisplatin in both human and rat renal epithelial cells. With regard to the mechanism of cisplatin-induced apoptosis, apoptosis-inducing factor (AIF) release into the cytosol was observed, and the underlying mechanism was identified as voltage-dependent anion channel (VDAC) oligomerization. Mitochondrial membrane potential (Δψm) was found to be greatly disrupted in cisplatin-treated cells. Moreover, cisplatin strongly induced translocation of annexin A5 into mitochondria. To understand the functional significance of annexin A5 in renal cell death, we used a siRNA-mediated approach to knock down annexin A5. Annexin A5 depletion by siRNA led to decreased annexin A5 translocation into mitochondria and significantly reduced VDAC oligomerization and AIF release. Annexin A5 siRNA also increased cell viability compared with the control. Moreover, expression of annexin A5 was induced by other nephrotoxicants such as CdCl2 and bacitracin. Taken together, our data suggest that annexin A5 may play a crucial role in cisplatin-induced toxicity by mediating the mitochondrial apoptotic pathway via the induction and oligomerization of VDAC.

Entities:  

Keywords:  Annexin; Annexin A5; Cisplatin; Kidney; Mitochondrial Apoptosis; Nephrotoxicity; Protein Translocation; Renal Epithelial Cell; VDAC; siRNA

Mesh:

Substances:

Year:  2013        PMID: 24318879      PMCID: PMC3900989          DOI: 10.1074/jbc.M113.450163

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Authors:  Navjotsingh Pabla; Guie Dong; Man Jiang; Shuang Huang; M Vijay Kumar; Robert O Messing; Zheng Dong
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Apoptosis is regulated by the VDAC1 N-terminal region and by VDAC oligomerization: release of cytochrome c, AIF and Smac/Diablo.

Authors:  Varda Shoshan-Barmatz; Nurit Keinan; Salah Abu-Hamad; Dalia Tyomkin; Lior Aram
Journal:  Biochim Biophys Acta       Date:  2010-03-06

3.  Cardiac resynchronization therapy-induced left ventricular reverse remodelling is associated with reduced plasma annexin A5.

Authors:  Susana Ravassa; Ignacio García-Bolao; Amaia Zudaire; Alfonso Macías; Juan J Gavira; Javier Beaumont; Teresa Arias; Ana Huerta; Javier Díez
Journal:  Cardiovasc Res       Date:  2010-06-11       Impact factor: 10.787

4.  Mitochondria as a target of cadmium nephrotoxicity: induction of swelling and cytochrome C release.

Authors:  Wing-Kee Lee; Ulrich Bork; Frank Thévenod
Journal:  Toxicol Mech Methods       Date:  2004       Impact factor: 2.987

Review 5.  Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure.

Authors:  M van Engeland; L J Nieland; F C Ramaekers; B Schutte; C P Reutelingsperger
Journal:  Cytometry       Date:  1998-01-01

6.  Urinary annexin V in children with nephrotic syndrome: a new prognostic marker?

Authors:  Behcet Simsek; Mithat Buyukcelik; Mustafa Soran; Aysun K Bayazit; Aytul Noyan; Gulsah Seydaoglu; Ali Anarat
Journal:  Pediatr Nephrol       Date:  2007-11-13       Impact factor: 3.714

7.  Validation of putative genomic biomarkers of nephrotoxicity in rats.

Authors:  Er-Jia Wang; Ronald D Snyder; Mark R Fielden; Roger J Smith; Yi-Zhong Gu
Journal:  Toxicology       Date:  2008-01-16       Impact factor: 4.221

Review 8.  Particular aspects of platinum compounds used at present in cancer treatment.

Authors:  Bernard Desoize; Claudie Madoulet
Journal:  Crit Rev Oncol Hematol       Date:  2002-06       Impact factor: 6.312

9.  Regulation of macrophage IL-10 production postinjury via beta2 integrin signaling and the P38 MAP kinase pathway.

Authors:  Martin G Schwacha; Irshad H Chaudry; Michelle Alexander
Journal:  Shock       Date:  2003-12       Impact factor: 3.454

Review 10.  Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death?

Authors:  Céline Candé; Francesco Cecconi; Philippe Dessen; Guido Kroemer
Journal:  J Cell Sci       Date:  2002-12-15       Impact factor: 5.285

View more
  16 in total

1.  Panax notoginseng saponins attenuates cisplatin-induced nephrotoxicity via inhibiting the mitochondrial pathway of apoptosis.

Authors:  Xinwen Liu; Zhenguang Huang; Xiaoqin Zou; Yufang Yang; Yue Qiu; Yan Wen
Journal:  Int J Clin Exp Pathol       Date:  2014-11-15

2.  Annexin A5 suppression promotes the progression of cervical cancer.

Authors:  Xiaojie Wang; Yarui Dai; Jialu Zhang; Xin Li
Journal:  Arch Gynecol Obstet       Date:  2022-07-07       Impact factor: 2.344

3.  FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells.

Authors:  Ming-Ju Huang; Wei Zhang; Qi Wang; Zhi-Jun Yang; Sheng-Bin Liao; Li Li
Journal:  J Ovarian Res       Date:  2018-02-13       Impact factor: 4.234

4.  Renal Medulla is More Sensitive to Cisplatin than Cortex Revealed by Untargeted Mass Spectrometry-Based Metabolomics in Rats.

Authors:  Pei Zhang; Jia-Qing Chen; Wan-Qiu Huang; Wei Li; Yin Huang; Zun-Jian Zhang; Feng-Guo Xu
Journal:  Sci Rep       Date:  2017-03-16       Impact factor: 4.379

5.  Exploring the Therapeutic Mechanism of Desmodium styracifolium on Oxalate Crystal-Induced Kidney Injuries Using Comprehensive Approaches Based on Proteomics and Network Pharmacology.

Authors:  Jiebin Hou; Wei Chen; Hongtao Lu; Hongxia Zhao; Songyan Gao; Wenrui Liu; Xin Dong; Zhiyong Guo
Journal:  Front Pharmacol       Date:  2018-06-13       Impact factor: 5.810

6.  Annexin A5 suppresses cyclooxygenase-2 expression by downregulating the protein kinase C-ζ-nuclear factor-κB signaling pathway in prostate cancer cells.

Authors:  Hyoung-Seok Baek; Nahee Park; Yeo-Jung Kwon; Dong-Jin Ye; Sangyun Shin; Young-Jin Chun
Journal:  Oncotarget       Date:  2017-07-19

7.  Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance.

Authors:  Chong-Bing Sun; Ai-Yan Zhao; Shuai Ji; Xiao-Qing Han; Zuo-Cheng Sun; Meng-Chun Wang; Fu-Chang Zheng
Journal:  World J Gastroenterol       Date:  2017-10-21       Impact factor: 5.742

8.  Role of annexin a5 on mitochondria-dependent apoptosis induced by tetramethoxystilbene in human breast cancer cells.

Authors:  Mihye Hong; Nahee Park; Young-Jin Chun
Journal:  Biomol Ther (Seoul)       Date:  2014-11-30       Impact factor: 4.634

9.  A Mechanism for the Temporal Potentiation of Genipin to the Cytotoxicity of Cisplatin in Colon Cancer Cells.

Authors:  Ruihua Wang; K C MoYung; Y J Zhao; Karen Poon
Journal:  Int J Med Sci       Date:  2016-06-29       Impact factor: 3.738

10.  Auranofin Suppresses Plasminogen Activator Inhibitor-2 Expression through Annexin A5 Induction in Human Prostate Cancer Cells.

Authors:  Dong-Won Shin; Yeo-Jung Kwon; Dong-Jin Ye; Hyoung-Seok Baek; Joo-Eun Lee; Young-Jin Chun
Journal:  Biomol Ther (Seoul)       Date:  2017-03-01       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.